Name: Cartalax 20mg (30 Vials / Kit)
Brand: Jinlu Peptides
SKU: JL-CARTALAX
Price: 276.30 USD
Availability: InStock

Cartalax at a glance

Cartalax is a tripeptide made of alanine, glutamic acid and aspartic acid. It belongs to the family of short bioregulator peptides developed in St. Petersburg under Vladimir Khavinson, a program that assigns each sequence to a target tissue based on earlier work with extracts from that tissue. Cartalax is the member associated with cartilage, so its literature concerns joint aging and the biology of the cartilage matrix. Listings are supplied as freeze-dried powder.

Price and availability

Jinlu Peptides lists this kit of 30 vials at 20mg each (600 mg in total), shipped from China. $276.30 buys the whole kit, which is $0.461/mg. Across 4 brands listing Cartalax here, the middle half of prices falls between $0.461 and $0.55 per mg; this kit is inside that range. As with every order here, the brand is paid only after you confirm delivery.

This listing: Jinlu Peptides Cartalax

Brand: Jinlu Peptides
Kit: 30 vials × 20 mg (600 mg in total)
Price per vial: $9.21
Price per mg: $0.46
Also sold by: SSRBIO 20mg $92.10 · TFC Peptides 20mg $110.00 · Uther Peptide 20mg $150.00

Lab testing

There is no public lab report for this listing yet. We can ask the brand for the batch COA before you order. Many buyers also split an independent HPLC test with others who bought the same batch.

Request the batch COA · How group testing works

Bought through escrow: the brand is only paid after you confirm delivery. If the parcel never arrives, or an independent test shows the wrong compound or a significant under-fill, open a claim before releasing payment.

What it is studied for

No surface receptor has been identified for Cartalax. Like related short peptides, it is hypothesized to enter cells and act on chromatin, nudging the expression of genes involved in chondrocyte division and the production of matrix proteins such as collagen. Some cartilage-cell studies also report lower markers of inflammation and of cellular aging. These observations fit the proposed mechanism but do not prove it, and the pathway has not been mapped in independent laboratories.

Research and regulatory status

Evidence comes from chondrocyte cultures and small animal studies related to osteoarthritis and cartilage wear, largely published by the originating research network. The scale of this work is modest, independent replication is scarce, and there are no controlled human trials. Cartalax has no approval as a medicine. Its value for now is as a tool for researchers exploring the short-peptide hypothesis in connective tissue.

Checking the lab data

Tripeptides offer few analytical handles, so identity confirmation matters most. The certificate should include mass spectrometry matching Ala-Glu-Asp, and preferably sequence confirmation, because a reordered chain such as Glu-Ala-Asp would weigh exactly the same. HPLC purity with the chromatogram, measured content per vial and a description of a white freeze-dried powder are the other essentials. Testing lab, method and batch number should all be stated.

This listing has no third-party report on file yet. The lab reports directory and the marketplace show which brands do publish testing.

Listing details

Compound: Cartalax
Synonyms: AED peptide (Ala-Glu-Asp)
Class: Synthetic tripeptide bioregulator
Format: Lyophilized (freeze-dried) powder
Vial strength: 20mg
Vials per kit: 30
Total content: 600 mg
Price per mg: $0.461
Sold by: Jinlu Peptides
Ships from: China
Lab report: Not yet published

Storage and preparation

Freeze-dried peptide keeps best sealed, cold and dark. Once it has been dissolved, refrigerate it, avoid repeated warming and follow the stability limits in your study protocol.

Concentration arithmetic: one 20 mg vial dissolved in 2 mL gives 10 mg/mL, or 20 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Why are bioregulator peptides linked to specific tissues?

The program that created them began by extracting peptide fractions from animal organs and then designing short synthetic sequences intended to reproduce the activity of each extract. The tissue association comes from that origin and from the group's own experiments. It is a classification used within that research tradition, not an established finding of tissue-specific receptors.

Is Cartalax used in any approved joint product?

No. It has no regulatory approval as a drug for joint or cartilage conditions in the United States or Europe. Some bioregulator peptides are sold as dietary supplements in certain markets, but that status says nothing about efficacy. On this marketplace, Cartalax is listed strictly as a research material.

How much Cartalax is in this listing?

30 vials of 20mg each — 600 mg in all. Where a lab report exists, the testing panel above shows what the brand's tested sample actually measured.

What if the parcel never arrives?

Open a claim from your order page. The payment is still in escrow at that point, so a claim decided in your favour is refunded to your Escrow Wallet.

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.